Patents by Inventor Ranit Kedmi

Ranit Kedmi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12668643
    Abstract: A lipidated secondary antibody is disclosed. Particles comprising same are also disclosed.
    Type: Grant
    Filed: June 7, 2023
    Date of Patent: June 30, 2026
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Ranit Kedmi, Nuphar Veiga, Itai Benhar, Dan Peer
  • Publication number: 20230312745
    Abstract: A lipidated secondary antibody is disclosed. Particles comprising same are also disclosed.
    Type: Application
    Filed: June 7, 2023
    Publication date: October 5, 2023
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Ranit KEDMI, Nuphar VEIGA, Itai BENHAR, Dan PEER
  • Patent number: 11708421
    Abstract: A lipidated secondary antibody is disclosed. Particles comprising same are also disclosed.
    Type: Grant
    Filed: July 18, 2017
    Date of Patent: July 25, 2023
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Ranit Kedmi, Nuphar Veiga, Itai Benhar, Dan Peer
  • Patent number: 11338042
    Abstract: A pharmaceutical composition comprising an immunoparticle is provided. The pharmaceutical composition comprising a monoclonal secondary antibody immunocomplexed with a primary antibody, wherein said monoclonal secondary antibody is coupled on an outer surface of a particle and wherein said particle is loaded with a pharmaceutical agent.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: May 24, 2022
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Ranit Kedmi, Dan Peer
  • Publication number: 20200101170
    Abstract: A pharmaceutical composition comprising an immunoparticle is provided. The pharmaceutical composition comprising a monoclonal secondary antibody immunocomplexed with a primary antibody, wherein said monoclonal secondary antibody is coupled on an outer surface of a particle and wherein said particle is loaded with a pharmaceutical agent.
    Type: Application
    Filed: December 3, 2019
    Publication date: April 2, 2020
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Ranit KEDMI, Dan PEER
  • Patent number: 10543278
    Abstract: A pharmaceutical composition comprising an immunoparticle is provided. The pharmaceutical composition comprising a monoclonal secondary antibody immunocomplexed with a primary antibody, wherein said monoclonal secondary antibody is coupled on an outer surface of a particle and wherein said particle is loaded with a pharmaceutical agent.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: January 28, 2020
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Ranit Kedmi, Dan Peer
  • Publication number: 20190309087
    Abstract: A lipidated secondary antibody is disclosed. Particles comprising same are also disclosed.
    Type: Application
    Filed: July 18, 2017
    Publication date: October 10, 2019
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Ranit KEDMI, Nuphar VEIGA, Itai BENHAR, Dan PEER
  • Publication number: 20150246135
    Abstract: A pharmaceutical composition comprising an immunoparticle is provided. The pharmaceutical composition comprising a monoclonal secondary antibody immunocomplexed with a primary antibody, wherein said monoclonal secondary antibody is coupled on an outer surface of a particle and wherein said particle is loaded with a pharmaceutical agent.
    Type: Application
    Filed: September 12, 2013
    Publication date: September 3, 2015
    Inventors: Ranit Kedmi, Dan Peer